erythropoietin analog(Bolder BioTechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Nameerythropoietin analog(Bolder BioTechnology)
Drug Alias NameBBT-021
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesBolder Biotechnology
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A